Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Androgenic alopecia (AGA), or pattern baldness, affects millions globally, leading to psychological distress. Current treatments include topical minoxidil, oral finasteride and transplants. Low‐dose oral minoxidil has emerged as a potential alternative due to its efficacy and reduced systemic side effects. This case series recruited AGA patients aged 18‐65 from a Tamil Nadu hospital. Informed consent was obtained and baseline assessments conducted. Patients received oral minoxidil starting at 0.5 mg/day, with dosage adjustments based on response. Follow‐up visits assessed treatment progress and adverse events over 6‐8 months. Demographics revealed a diverse patient population, predominantly aged 20‐39 (63.64% male). Most experienced hair loss for over 10 years (86.36%). Analysis showed notable improvements in hair growth parameters over 20 weeks, with increases in hair count, density, and diameter observed. Low‐dose oral minoxidil presents a promising therapeutic option for AGA, offering a balance between efficacy and safety. Personalized treatment regimens tailored to individual needs are crucial, highlighting the importance of continued research to establish optimal dosages and long‐term effects.
How to cite this article:
Agnes Varshini, A.J.S. Pravin, Nivin Simon and Azeem Jaffer. Oral Minoxidil‐A Powerful Tool for Treating Androgenic Alopecia: Case Series.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.7.341.345
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.7.341.345